Cargando…
Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo
Doxorubicin (DOX) is considered as one of the best antineoplastic agents. However, its clinical use is restricted by its associated cardiotoxicity, which is mediated by the production of reactive oxygen species. In this study, 20(S)-ginsenoside Rh2 (Rh2) was explored whether it had protective effect...
Autores principales: | Wang, Hongbo, Yu, Pengfei, Gou, Haitao, Zhang, Jianqiao, Zhu, Mei, Wang, Zhen-hua, Tian, Jing-wei, Jiang, Yong-tao, Fu, Feng-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483725/ https://www.ncbi.nlm.nih.gov/pubmed/23125868 http://dx.doi.org/10.1155/2012/506214 |
Ejemplares similares
-
In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review
por: Zhang, Qian, et al.
Publicado: (2022) -
Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Argun, Mustafa, et al.
Publicado: (2016) -
Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Tseng, Yi-Tang
Publicado: (2016) -
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
por: Timm, Kerstin N., et al.
Publicado: (2020) -
The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
por: Zilinyi, Rita, et al.
Publicado: (2018)